Here are three things to know.
- Protein Sciences is also eligible to receive up to $100 million in milestone payments.
- Through the acquisition, Sanofi will gain the rights to the flu vaccine Flublok. Unlike most vaccines grown in chicken eggs, Flublok is produced using a technology that rearranges genetic material to make the vaccine.
- The deal is expected to close in the third quarter of this year.
More articles on supply chain:
How Trump’s efforts to lower drug prices affect the industry — 4 questions on a possible executive order
Suburban Hospital wants to compete with MedStar Georgetown for liver transplants
Why supply chain leaders should practice unlearning
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.